IMMUNOCELLULAR THE (IMUC)

0.04
0.00 7.50
OTC
Prev Close 0.04
Open 0.04
Day Low/High 0.03 / 0.04
52 Wk Low/High 0.03 / 0.55
Volume 4.13M
Exchange OTC
Shares Outstanding 41.94B
Market Cap 1.85M
Div & Yield N.A. (N.A)

Latest News

ImmunoCellular Therapeutics Provides Corporate Update And Reports Second Quarter 2018 Financial Results

ImmunoCellular Therapeutics Provides Corporate Update And Reports Second Quarter 2018 Financial Results

-Ongoing Exploration of Strategic Opportunities-

ImmunoCellular Therapeutics Announces Agreement On Terms Of Settlement Of Federal Class Action Shareholder Lawsuit

ImmunoCellular Therapeutics Announces Agreement On Terms Of Settlement Of Federal Class Action Shareholder Lawsuit

Settlement Will Be Paid By Company's Insurance Carrier

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of ImmunoCellular Therapeutics, Ltd. Shareholders And A Lead Plaintiff Deadline Of June 30, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunoCellular Therapeutics, Ltd.

The Klein Law Firm Notifies Investors Of A Class Action Filed On Behalf Of ImmunoCellular Therapeutics, Ltd. Shareholders And A Lead Plaintiff Deadline Of June 30, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunoCellular Therapeutics, Ltd.

IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Immunocellular Therapeutics, Ltd. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ImmunoCellular Therapeutics, Ltd.

IMUC SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving ImmunoCellular Therapeutics, Ltd. And A Lead Plaintiff Deadline Of June 30, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased ImmunoCellular...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of ImmunoCellular Therapeutics, Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of June 30, 2017 - IMUC

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCellular Therapeutics, Ltd.

IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ImmunoCellular Therapeutics, Ltd. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ImmunoCellular Therapeutics, Ltd.

IMUC EQUITY ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving ImmunoCellular Therapeutics, Ltd. And A Lead Plaintiff Deadline Of June 30, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased ImmunoCellular...

IMUC LOSS NOTICE: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. Of Important Deadline In Class Action - IMUC

Rosen Law Firm, a global investor rights law firm, reminds purchasers of ImmunoCellular Therapeutics, Ltd.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of ImmunoCellular Therapeutics, Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of June 30, 2017 - IMUC

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCellular Therapeutics, Ltd.

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. And Encourages Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against ImmunoCellular Therapeutics, Ltd.

INVESTOR ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd.

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against ImmunoCellular Therapeutics, Ltd.

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against ImmunoCellular Therapeutics, Ltd.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. - IMUC

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of ImmunoCellular Therapeutics, Ltd.

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Blame for Northwest Bio Collapse Lies With CEO, Not With Mythical 'Wolfpack'

Blame for Northwest Bio Collapse Lies With CEO, Not With Mythical 'Wolfpack'

A defrocked analyst brushes off the serious problems weighing on Northwest Bio. Instead, he jacks the tired 'blame the shorts' excuse to another level.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

4 Stocks Under $10 to Trade for Breakouts

4 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

SEC Casting Wide Net in Galena Investigation

SEC Casting Wide Net in Galena Investigation

Lion Bio received an SEC subpoena related to the Galena DreamTeam investigation.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

First Week of April 19th Options Trading For ImmunoCellular Therapeutics (IMUC)

First Week of April 19th Options Trading For ImmunoCellular Therapeutics (IMUC)

Investors in ImmunoCellular Therapeutics Ltd saw new options begin trading this week, for the April 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IMUC options chain for the new April 19th contracts and identified the following call contract of particular interest.

3 Stocks Under $10 Moving Higher

3 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due

Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due

Twelve weeks have passed since Northwest Bio said an interim analysis of the DCVax phase III study was underway. Where are the results?

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular

Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

ImmunoCellular Therapeutics Announces First Patient Receives Vaccine In Phase I Trial Of Cancer Vaccine ICT-121 In Recurrent Glioblastoma

ImmunoCellular Therapeutics Announces First Patient Receives Vaccine In Phase I Trial Of Cancer Vaccine ICT-121 In Recurrent Glioblastoma

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) announced today that the first patient in the phase I clinical trial of ICT-121, a cancer vaccine targeting recurrent glioblastoma multiforme ...